Sanggenol P

CAS No. 1351931-30-0

Sanggenol P( —— )

Catalog No. M31355 CAS No. 1351931-30-0

Sanggenol P is a natural product of Morus, Moraceae. Sanggenol P can be used as a reference standard.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 2502 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Sanggenol P
  • Note
    Research use only, not for human use.
  • Brief Description
    Sanggenol P is a natural product of Morus, Moraceae. Sanggenol P can be used as a reference standard.
  • Description
    Sanggenol P is a natural product of Morus, Moraceae. Sanggenol P can be used as a reference standard.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1351931-30-0
  • Formula Weight
    492.6
  • Molecular Formula
    C30H36O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • KISS1-305

    KISS1-305, the Metastin/Kisspeptin analog, is a prototype peptide and a chemical probe. KISS1-305 has suboptimal KISS1R agonistic activity, and resists plasma protease degradation.KISS1-305 is a proto- type peptide that resists plasma protease degradation but has suboptimal KISS1R agonistic activity in vitro.

  • Goxalapladib

    Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.

  • Salusin-α

    Salusin-α is an endogenous bioactive peptide with hemodynamic and cell proliferation activities. Salusin-α can stimulate the proliferation of quiescent vascular smooth muscle cells (VSMCs) and fibroblasts, leading to a rapid and significant decrease in blood pressure and heart rate, but its effect is weaker than that of Salusin-β . Salusin-α has potential application value in cardiovascular disease research.